Inhibition of bacterial multiplication by the iron chelator deferoxamine: Potentiating effect of ascorbic acid B. S. van AsbeckJ. H. MarcelisJ. Verhoef Original Articles Pages: 426 - 431
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin B. S. van AsbeckJ. H. MarcelisJ. Verhoef Original Articles Pages: 432 - 438
Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations onStaphylococcus aureus andPseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes M. BasslerW. DepuisF. D. Daschner Original Articles Pages: 439 - 444
Effects of subinhibitory concentrations of ketoconazole on in vitro adherence ofCandida albicans to vaginal epithelial cells J. D. SobelN. Obedeanu Original Articles Pages: 445 - 452
Cross-reacting opsonic antibodies to clinically important pneumococcal serotypes after pneumococcal vaccination J. H. BraconierE. B. MyhreH. Odeberg Original Articles Pages: 453 - 458
Experimental animal model of surgical wound infection applicable to antibiotic prophylaxis F. MoesgaardM. C. Lykkegaard NielsenT. Justesen Original Articles Pages: 459 - 462
Dissemination of streptomycin and sulfonamide resistance by plasmid pBP1 inEscherichia coli G. KorfmannW. LüdtkeB. Wiedemann Original Articles Pages: 463 - 468
Biliary tract infections caused byHaemophilus influenzae type b R. PallarésA. Sitges-SerraF. Gudiol Case Report Pages: 469 - 472
Cotrimoxazole resistance in pneumococci J. LinaresJ. L. PérezR. Martin Correspondence Pages: 473 - 474
Rate of isolation ofStaphylococcus aureus strains possessing coagulase or clumping factor S. P. Barrett Correspondence Pages: 475 - 476
Characterization ofStaphylococcus saprophyticus strains isolated from the Urethra and the Vagina A. Tselenis-KotsowilisP. DimouJ. Papavassiliou Correspondence Pages: 476 - 477
Enterotoxin production, invasive ability and surface antigens of enteropathogenicEscherichia coli A. Thoren Correspondence Pages: 478 - 479
In vitro activity of norfloxacin againstMycoplasma hominis andUreaplasma urealyticum C. SimonU. Lindner Correspondence Pages: 479 - 480
Serotype distribution ofStreptococcus pneumoniae in hospitalized patients in Israel S. Bergner-RabinowitzE. SimchenJ. Michel Correspondence Pages: 480 - 482
In vitro and in vivo synergy between ceftriaxone and aminoglycosides againstPseudomonas aeruginosa P. Angehrn OriginalPaper Pages: 489 - 495
Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin K. MachkaR. Dietz OriginalPaper Pages: 496 - 500
Pharmacokinetic and microbial susceptibility studies of ceftriaxone J. D. BaumgartnerM. P. Glauser OriginalPaper Pages: 501 - 504
A comparison of the pharmacokinetics and tissue penetration of ceftriaxone, moxalactam and cefotaxime R. WiseJ. M. Andrews OriginalPaper Pages: 505 - 508
Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children E. Martin OriginalPaper Pages: 509 - 515